Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Nov 6, 2022; 10(31): 11607-11616
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11607
Table 1 Laboratory data (reference range, units)
Laboratory data

(Reference range, units)
Hematology
WBC5290(3300-8600, /μL)
Neu61.5(40.0-70.0, %)
Ly29.1(16.5-49.5, %)
Mono6.0(2.0-10.0, %)
Eos2.4(0.0-8.5, %)
Bas0.9(0.0-2.5, %)
RBC449(435-555, × 104/μL)
Hb14.1(13.7-16.8, g/dL)
Ht43.0(40.7-50.1, %)
PLT14.8(15.8-34.8, × 104/μL)
Coagulation
APTT32.1(26.9-38.1, sec)
PT82.0(73-118, %)
PT-INR1.1(< 2.99)
D-dimer2.2(0.0-0.9, μg/mL)
Biochemistry
TP7.4(6.6-8.1, g/dL)
Alb3.9(4.1-5.1, g/dL)
T.Bil0.67(0.40-1.50, mg/dL)
AST22(13-30, U/L)
ALT19(10-42, U/L)
γ-GTP15(38-75, U/L)
ALP91(38-113, U/L)
AMY95(44-132, U/L)
LIPA39(13-55, U/L)
BUN14.1(8.0-20.0, mg/dL)
CRE1.06(0.65-1.07, mg/dL)
Na137(138-145, mmol/L)
K4.4(3.6-4.8, mmol/L)
Cl105(101-108, mmol/L)
Ca9.4(8.8-10.1, mg/dL)
CRP0.05(< 0.15, mg/dL)
Tumor marker
CEA3.2(< 5.00, ng/mL)
CA19-92556(0.0-35.4, U/mL)
Immunoglobulin
IgG4280.5(4.5-117.0, mg/dL)